Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Announces Next Segment in Far-Reaching ‘Psychedelics for Alcoholism’ Series

Clearmind Medicine (CSE: CMND) (FSE: CWY0), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics, has announced the fifth webinar in its Psychedelics for Alcoholism series. This segment is titled “Psychedelics for Alcoholism, Q&A with Clearmind Management.” Scheduled for March 30, 2022, this insightful event will feature Clearmind CEO Adi Zuloff-Shani and […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Launches New European Routing Nodes, Now Providing Nine Active Nodes on Lightning Network

LQwD has recently deployed additional routing nodes in Europe, namely in Italy, Sweden, Ireland, England and France Since the US-West deployment in November 2021, LQwD has seen 157 nodes interconnected with more than 158 transaction channels over 10 Bitcoin through all channels Arcane Research predicts that there will be as many as 700 million Lightning […]

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Prepares Summer Gold Exploration Program in Ontario, Amid European War Era Instability

StraightUp Resources is a mining acquisition and exploration company with flagship properties in Ontario, Canada, and an expanding international footprint Following on the acquisition of aerial digital magnetic survey data last year for its flagship properties, the company is preparing a summer work program that will include analysis of its data, identification of key geological […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Phase of Epilepsy Research Using DehydraTECH(TM)-CBD

Lexaria’s patented DehydraTECH(TM) technology provides faster delivery times, increases bioavailability, increases brain absorption, improves drug potency, reduces administration costs, and masks unwanted flavors The epilepsy research will compare the FDA-approved Epidiolex(R) to the company’s proprietary DehydraTECH-CBD formulation The global cannabidiol (“CBD”) market had an estimated value of $2.7 billion in 2021 and is expected to […]

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

Flora Growth’s two late 2021 acquisitions added an estimated $35 million in revenue and $7 million in EBITDA Its acquisition of Vessel Brand Inc. is projected to bring $35-$45 million in revenue for the 2022 calendar year With these acquisitions, the company, an internationally focused cannabis brand builder with a global distribution platform, stamps its […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.